À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾

À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾Öêʽ»áÉ磨×ܲ¿£º¶«¾© £¬CEO£ºÄÚÌÙÇç·ò £¬¡°À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾¡±£©Ðû²¼ £¬À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾ £¬Í¨¹ý¹ºÖùɷݺÍÈϹºµÚÈý·½·ÖÅäµÄÆÕͨ¹É £¬ÒÑÊÕ¹ºArteryex Inc.£¨×ܲ¿: ¶«¾© £¬CEO£ºLi Dongying £¬¡°Arteryex¡±£©¿¯ÐеĴó²¿ÃÅ¹É·Ý £¬ArteryexÊÇÒ»¼Ò¹æ»®ºÍ¿ª·¢ÓëÊý×Ö½â¾ö·½°¸Ïà¹ØµÄÈí¼þ¹«Ë¾ £¬²¢ÓÚ2022Äê3ÔÂ31ÈÕ³ÉΪÆä×Ó¹«Ë¾ ¡£Á½¼Ò¹«Ë¾½«ºÏ×÷Ϊ»¼Õß¡¢Ò½ÁƱ£½¡×¨ÒµÈËÔ±ºÍÕû¸öÉç»á¿ª·¢ºÍÌṩÓë¸öÈ˽¡¿µ¼Ç¼£¨PHR£©Ïà¹ØµÄ·þÎñ ¡£

À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾ÓÚ2021Äê4ÔÂÍƳöÁË¡°EWAY Future & Beyond¡±ÖÐÆÚÉÌÒµ¼Æ»® £¬½«ÊӽǴӻ¼ÕßµÄÊÓ½ÇתÒƵ½ÈËÃñ»òÿһλÏû·ÑÕß ¡£À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾ÒÔ¡°ÈÃÈËÃñʵÏÖ×î³äʵµÄÉú»î¡±ÎªÔ¸¾° £¬ÀûÓÃÈ˹¤ÖÇÄܵÈ×îÐÂÊý×Ö¼¼Êõ £¬ÎªÈËÃñÌṩҩƷºÍ½â¾ö·½°¸ £¬Ö¼ÔÚÏû³ýÈËÃñµÄ½¹ÂÇ ¡£

ArteryexÓµÓÐÓÅÐãµÄÈí¼þ¿ª·¢ÄÜÁ¦ £¬¿ª·¢ÁË×Ô¼ºµÄPHRÏà¹Ø²úÎï·þÎñ £¬°üÂÞÓÃÓÚ´æ´¢ºÍת»»ÕýÔÚ½ÓÊÜÖÎÁÆ»¼Õß½¡¿µÏà¹ØÐÅÏ¢ºÍ´óÁ¿µÄÓû§Â¼ÈëÊý¾ÝµÄÓ¦Ó÷¨Ê½£¨APP£©ÒÔ¼°ÓÃÓÚ¹«Ë¾Ô±¹¤½¡¿µ¹ÜÀíµÄÓ¦Ó÷¨Ê½ ¡£

À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾Ö¼ÔÚͨ¹ý×Ó¹«Ë¾ÊÕ¹º»ñµÃArteryexµÄ¿ª·¢ÄÜÁ¦ºÍÓÅÖʵÄPHR²úÎï £¬´Ó¶ø¼ÓÇ¿ºÍ¿ìËÙÀ©Õ¹ÆäÊý×Ö½â¾ö·½°¸ÒµÎñ»ù´¡ ¡£³ýÁ˽Ӵ¥ÏÖÓвúÎïµÄпͻ§ÈºÌåÍâ £¬À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾»¹½«Í¨¹ýÀûÓÃArteryexµÄÊäÈë¼¼ÊõºÍͼÏñÊý¾Ýϵͳ £¬´Ù½ø¿ª·¢°üÂÞÐÂÓ¦ÓÃÔÚÄڵIJúÎï ¡£´ËÍâ £¬×÷ΪÕû¸öÀ´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾¼¯ÍÅ £¬À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾½«Ìá¸ßͨ¹ýPHRÏà¹Ø²úÎï»ñµÃµÄÊý¾ÝÀûÓÃÂÊ £¬ÀûÓÃÀ´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾ÔÚÆäÒ©ÎïµÞÔì»î¶¯ºÍ¼²²¡ÈÏÖª»î¶¯ÖÐÖÖÖÖʵ¼ù½øÒ»²½ÓÅ»¯Êý¾Ý¹ÜÀí ¡£

ΪÁ˹¹½¨À´Àû¹ú¼Êw66¹Ù·½ÍøվͨÓÃƽ̨(EUP) £¬Í¨¹ýÕâЩ¾Ù´ë £¬À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾½«¼ÓÇ¿´´½¨Ò»À¿×Ó½â¾ö·½°¸ £¬²¢¼Óǿά»¤ºÍÌá¸ß½¡¿µ¡¢Ô¤·ÀºÍ¼²²¡ÈÏÖªµÄ»ù´¡ÉèÊ© £¬²¢½«À©´ó¶ÔÈËÃñµÄТ¾´ ¡£

³ÉΪ×Ó¹«Ë¾ºó £¬ArteryexÏÖÈιÜÀíÍŶӽ«¼ÌÐø´æÔÚ ¡£À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾ÊÕ¹ºArteryex×÷Ϊ×Ó¹«Ë¾²»»á¶ÔArteryexµÄºÏ²¢²ÆÕþÒµ¼¨·¢ÉúÖØ´óÓ°Ïì ¡£

Media Inquiries:
Public Relations Department,
Eisai Co., Ltd.
+81-(0)3-3817-5120

ÍøÕ¾µØͼ